Cargando…
Theory and applications of differential scanning fluorimetry in early-stage drug discovery
Differential scanning fluorimetry (DSF) is an accessible, rapid, and economical biophysical technique that has seen many applications over the years, ranging from protein folding state detection to the identification of ligands that bind to the target protein. In this review, we discuss the theory,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040159/ https://www.ncbi.nlm.nih.gov/pubmed/32006251 http://dx.doi.org/10.1007/s12551-020-00619-2 |
_version_ | 1783500925002842112 |
---|---|
author | Gao, Kai Oerlemans, Rick Groves, Matthew R. |
author_facet | Gao, Kai Oerlemans, Rick Groves, Matthew R. |
author_sort | Gao, Kai |
collection | PubMed |
description | Differential scanning fluorimetry (DSF) is an accessible, rapid, and economical biophysical technique that has seen many applications over the years, ranging from protein folding state detection to the identification of ligands that bind to the target protein. In this review, we discuss the theory, applications, and limitations of DSF, including the latest applications of DSF by ourselves and other researchers. We show that DSF is a powerful high-throughput tool in early drug discovery efforts. We place DSF in the context of other biophysical methods frequently used in drug discovery and highlight their benefits and downsides. We illustrate the uses of DSF in protein buffer optimization for stability, refolding, and crystallization purposes and provide several examples of each. We also show the use of DSF in a more downstream application, where it is used as an in vivo validation tool of ligand-target interaction in cell assays. Although DSF is a potent tool in buffer optimization and large chemical library screens when it comes to ligand-binding validation and optimization, orthogonal techniques are recommended as DSF is prone to false positives and negatives. |
format | Online Article Text |
id | pubmed-7040159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-70401592020-03-10 Theory and applications of differential scanning fluorimetry in early-stage drug discovery Gao, Kai Oerlemans, Rick Groves, Matthew R. Biophys Rev Review Differential scanning fluorimetry (DSF) is an accessible, rapid, and economical biophysical technique that has seen many applications over the years, ranging from protein folding state detection to the identification of ligands that bind to the target protein. In this review, we discuss the theory, applications, and limitations of DSF, including the latest applications of DSF by ourselves and other researchers. We show that DSF is a powerful high-throughput tool in early drug discovery efforts. We place DSF in the context of other biophysical methods frequently used in drug discovery and highlight their benefits and downsides. We illustrate the uses of DSF in protein buffer optimization for stability, refolding, and crystallization purposes and provide several examples of each. We also show the use of DSF in a more downstream application, where it is used as an in vivo validation tool of ligand-target interaction in cell assays. Although DSF is a potent tool in buffer optimization and large chemical library screens when it comes to ligand-binding validation and optimization, orthogonal techniques are recommended as DSF is prone to false positives and negatives. Springer Berlin Heidelberg 2020-01-31 /pmc/articles/PMC7040159/ /pubmed/32006251 http://dx.doi.org/10.1007/s12551-020-00619-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Gao, Kai Oerlemans, Rick Groves, Matthew R. Theory and applications of differential scanning fluorimetry in early-stage drug discovery |
title | Theory and applications of differential scanning fluorimetry in early-stage drug discovery |
title_full | Theory and applications of differential scanning fluorimetry in early-stage drug discovery |
title_fullStr | Theory and applications of differential scanning fluorimetry in early-stage drug discovery |
title_full_unstemmed | Theory and applications of differential scanning fluorimetry in early-stage drug discovery |
title_short | Theory and applications of differential scanning fluorimetry in early-stage drug discovery |
title_sort | theory and applications of differential scanning fluorimetry in early-stage drug discovery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040159/ https://www.ncbi.nlm.nih.gov/pubmed/32006251 http://dx.doi.org/10.1007/s12551-020-00619-2 |
work_keys_str_mv | AT gaokai theoryandapplicationsofdifferentialscanningfluorimetryinearlystagedrugdiscovery AT oerlemansrick theoryandapplicationsofdifferentialscanningfluorimetryinearlystagedrugdiscovery AT grovesmatthewr theoryandapplicationsofdifferentialscanningfluorimetryinearlystagedrugdiscovery |